CINCINNATI, Jan. 6, 2026 /PRNewswire/ — LiverRight, the nation’s only National Virtual Clinic for diagnosing and treating Liver Disease in Adults, announces that its telemedicine appointments in 2026 will offer metrics collection using what’s called Contactless Remote Patient Monitoring (RPM).
The B3 GEL System maintains biomechanical separation throughout the essential healing window.
The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure monitoring in the U.S.
Stereotaxis (NYSE:STXS) has won FDA approval for its robotically navigated MAGiC ablation catheter, offering a minimally invasive option for patients who otherwise might not be eligible for cardiac ablation to treat complex and critical heart rhythm disorders.
W.L. Gore & Associates announced today that the FDA approved its Viabahn Fortegra venous stent, formerly known as Viafort.
Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced today that it plans to launch a new, FDA-cleared artificial heart accessory.
A comprehensive genetic investigation led by Dr. Feng Liu at Tianjin Medical University General Hospital has uncovered striking molecular connections between schizophrenia and bone health, identifying 195 shared genetic loci that may explain why psychiatric patients face elevated fracture risks.
Social robots are efficacious and effective for children with autism, according to a study published online Dec. 24 in Science Robotics.
KAIST researchers have developed a new device that can precisely reproduce how muscle and kidney damage influence each other simultaneously within the human body.
A study published in the journal eBioMedicine assesses the effectiveness of electrocardiograms (ECGs) analyzed via deep learning as a tool for early COPD detection.